The medical diagnostics industry has found an ally in its quest to restore patent eligibility for groundbreaking discoveries, even those involving natural phenomena.

Judge Kathleen O’Malley of the U.S. Court of Appeals for the Federal Circuit called on the full court to review its case law Tuesday even while voting to affirm the latest invalidation, this time on a Roche patent for quickly diagnosing drug-resistant tuberculosis.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]